Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Biotech
Regeneron stays out of ADC deal fray as scientists tinker
Regeneron is good at making antibodies. But while the industry has gone crazy for ADCs, the company has stayed out of the limelight.
Annalee Armstrong
Nov 15, 2023 9:11am
AbbVie CEO says company favored internal work over Daiichi deal
Oct 27, 2023 11:41am
Lupus Therapeutics, AbbVie partner for trials of SLE therapy
Oct 26, 2023 9:00am
AbbVie and Calico drug boosts immunotherapy response in mice
Oct 5, 2023 11:19am
AbbVie continues Parkinson's pursuit with $110M Mitokinin buy
Oct 5, 2023 10:30am
AbbVie ends Caribou CAR-T deal, continuing cascade of axed pacts
Sep 27, 2023 6:00am
